Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07437911 · ClinicalTrials.gov registry record · NA
A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs
A NA study of GLP-1 and Gastrointestinal Microbiome, sponsored by Athletic Greens International.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07437911: Recruiting NA study of GLP-1 and Gastrointestinal Microbiome, sponsored by Athletic Greens International.
NCT07437911 is a NA study of GLP-1 and Gastrointestinal Microbiome that is actively recruiting participants, run by Athletic Greens International. The registered enrollment target is 120 participants, above the 85-participant average among 7 other GLP-1 trials with a reported enrollment target (41% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07437911, a NA study of GLP-1 and Gastrointestinal Microbiome, is actively recruiting participants, sponsored by Athletic Greens International.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a triple-blind, placebo-controlled, randomized controlled trial of 120 adults that will evaluate the impact of a novel nutritional supplement on improving nutrient gaps and changing nutrient status and the gut microbiome among glucagon-like peptide-1 receptor agonist (GLP-1 RA) users.
Primary Outcome
Assess nutrient gaps by dietary record assessment utilizing The Automated Self-Administered 24-hour (ASA24®) Dietary Assessment Tool
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT AG1 - Nutritional Supplement
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-02 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT07437911 shows while recruiting
NCT07437911 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 85-participant average among 7 other GLP-1 trials with a reported enrollment target (41% higher).
The record links to 4 conditions, with GLP-1 appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07437911 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07437911 about?
NCT07437911 is a clinical study titled "A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs". This study is a triple-blind, placebo-controlled, randomized controlled trial of 120 adults that will evaluate the impact of a novel nutritional supplement on improving nutrient gaps and changing nutrient status and the gut microbiome among glucagon-like peptide-1 receptor agonist (GLP-1 RA) users.
What is the current status of trial NCT07437911?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2026-02. Estimated completion is 2026-08.
What conditions does trial NCT07437911 study?
This clinical trial studies the following conditions: GLP-1, Gastrointestinal Microbiome, Nutrition Status, Nutrition Intake.
What interventions are being tested in trial NCT07437911?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), AG1 - Nutritional Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07437911?
This trial is sponsored by Athletic Greens International, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07437911 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for GLP-1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
RECRUITING · NA
-
GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women
RECRUITING
-
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
RECRUITING · Phase 2
-
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy
RECRUITING
-
The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality
RECRUITING · Phase 4
-
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia